Instructions for Use (IFUs) for combination products should use clear, concise and nontechnical language whenever possible to help ensure they’re useful to patients, the US Food and Drug Administration says in a new draft guidance that includes specific wording recommendations.
The 20-page document applies to drug-device and biologic-device products that are submitted to the FDA under a new drug application...